We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
– -$119M -482,756 Closed
JSP
27
Jackson Square Partners
California
– -$105M -428,103 Closed
William Blair & Company
28
William Blair & Company
Illinois
– -$103M -420,582 Closed
Norges Bank
29
Norges Bank
Norway
– -$99.2M -403,666 Closed
American Century Companies
30
American Century Companies
Missouri
– -$96.8M -394,233 Closed
Charles Schwab
31
Charles Schwab
California
– -$91.5M -372,287 Closed
Legal & General Group
32
Legal & General Group
United Kingdom
– -$88.5M -360,162 Closed
CS
33
Credit Suisse
Switzerland
– -$87M -353,961 Closed
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
– -$78.8M -320,856 Closed
ACM
35
American Capital Management
New York
– -$66.5M -270,696 Closed
SEI Investments
36
SEI Investments
Pennsylvania
– -$63.5M -258,440 Closed
UBS AM
37
UBS AM
Illinois
– -$61.4M -250,069 Closed
Morgan Stanley
38
Morgan Stanley
New York
– -$61.4M -250,016 Closed
Allspring Global Investments
39
Allspring Global Investments
North Carolina
– -$61M -248,201 Closed
Alyeska Investment Group
40
Alyeska Investment Group
Illinois
– -$58.4M -237,857 Closed
SI
41
Scout Investments
Missouri
– -$58M -236,146 Closed
Axa
42
Axa
France
– -$55.4M -225,415 Closed
JP Morgan Chase
43
JP Morgan Chase
New York
– -$53.6M -218,051 Closed
Bank of America
44
Bank of America
North Carolina
– -$51.4M -209,427 Closed
Swiss National Bank
45
Swiss National Bank
Switzerland
– -$48.5M -197,314 Closed
N
46
Nuveen
North Carolina
– -$48.4M -197,202 Closed
Amundi
47
Amundi
France
– -$50M -189,134 Closed
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
– -$42.9K -170,783 Closed
BG
49
Bellevue Group
Switzerland
– -$40.9M -166,355 Closed
Deutsche Bank
50
Deutsche Bank
Germany
– -$40.3M -164,019 Closed
1
2
3 4 5

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.